1. Alternative enzymes as a special strategy for the adaptation of procaryotic organisms (Review)
   E. P. Ryzhkova, 2017, Appl Biochem Microbiol CrossRef
2. Advances in prognostic biomarkers for esophageal cancer
   Wanli Yang et al, 2018, Expert Review of Molecular Diagnostics CrossRef
3. Effect of 5-fluorouracil on cellular response to proton beam in esophageal cancer cell lines according to the position of spread-out Bragg peak
   Hidehiro Hojo et al, 2019, Acta Oncologica CrossRef
4. Precision Medicine and Pancreatic Cancer
   James J. Farrell et al, 2016, Pancreas CrossRef
5. THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5‐fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis
   Masato Hayashi et al, 2019, J Gene Med CrossRef
6. Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
   Tomotaka Kato et al, 2021, PLoS One CrossRef
7. Molecular mechanisms associated with chemoresistance in esophageal cancer
   Matheus Lohan-Codeço et al, 2022, Cell. Mol. Life Sci. CrossRef
8. Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
   Anthi Maslarinou et al, 2023, Front. Pharmacol. CrossRef
9. Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies
   Xue-Man Dong et al, 2025, Cancer Gene Ther CrossRef